Bruceae Fructus’ primary targets against laryngeal cancer were IL6, JUN, TNF, IL2, IL4, IFNG, RELA, TP53, CDKN1A, and AKT1. GO enrichment yielded 41 CC, 78 MF, and 383 BP. This evidence concerns the gene TP53 and laryngeal carcinoma.